Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · IEX Real-Time Price · USD
4.900
-0.190 (-3.73%)
At close: Mar 27, 2024, 4:00 PM
5.25
+0.35 (7.14%)
After-hours: Mar 27, 2024, 7:59 PM EDT

BDTX Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017
Net Income
-82.44-91.17-125.6-67.25-35.26-8.93-4.6
Depreciation & Amortization
0.440.510.210.050.050.040.02
Share-Based Compensation
9.612.214.047.773.640.060.01
Other Operating Activities
5.68-6.6211.217.296.890.372.22
Operating Cash Flow
-66.72-85.08-100.15-52.15-24.67-8.45-2.35
Capital Expenditures
0.06-0.18-2.71-0.14-0.02-0.08-0.08
Change in Investments
16.2853.55133.32-281.55000
Investing Cash Flow
16.3553.37130.61-281.69-0.02-0.08-0.08
Share Issuance / Repurchase
71.930.180.73214.94000.1
Debt Issued / Paid
000000-0.05
Other Financing Activities
----127.7652.319.92
Financing Cash Flow
71.930.180.73214.94127.7652.319.97
Net Cash Flow
21.56-31.5431.19-118.89103.0643.787.55
Free Cash Flow
-66.66-85.27-102.86-52.29-24.7-8.53-2.43
Free Cash Flow Per Share
-1.52-2.35-2.84-1.59-11.90-4.23-1.26
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).